Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complications of primary retroperitoneal lymph node dissection

J Baniel1, R S Foster, R G Rowland

  • 1Department of Urology, Indiana University School of Medicine, Indianapolis.

The Journal of Urology
|August 1, 1994
PubMed
Summary

Primary retroperitoneal lymph node dissection for early testicular cancer has low surgical morbidity. Nerve-sparing techniques ensure high ejaculation rates, making it a safe option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.

Actas urologicas espanolas·2021
Same author

Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction - clinical outcome and quality of life: a bi-center prospective study.

BMC urology·2019
Same author

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.

World journal of urology·2018
Same author

Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."

Urologic oncology·2018
Same author

Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.

World journal of urology·2018

Area of Science:

  • Urology
  • Surgical Oncology

Background:

  • Nonseminomatous testicular cancer requires effective treatment with minimal side effects.
  • Retroperitoneal lymph node dissection (RPLND) is a key surgical option for early-stage disease.

Purpose of the Study:

  • To review surgical morbidity associated with primary retroperitoneal lymph node dissection (RPLND) in clinical stages I and II nonseminomatous testicular cancer.
  • To evaluate the impact of surgical techniques and experience on complication rates and functional outcomes.

Main Methods:

  • Retrospective review of 478 patients undergoing primary RPLND between 1982 and 1992.
  • Analysis of complication types, rates, and contributing factors.
  • Assessment of ejaculation rates in patients who underwent nerve-sparing procedures.

Related Experiment Videos

Main Results:

  • Overall complication rate was 10.6% (51/478 patients) with no operative mortality.
  • Superficial wound infection was the most common complication (45% of total).
  • Modified unilateral procedures (9.4%) and procedures from 1987-1992 showed significantly lower complication rates compared to bilateral dissections (19.3%).
  • Nerve-sparing techniques achieved a 98% ejaculation rate.

Conclusions:

  • Primary RPLND for early-stage testicular cancer is associated with minimal morbidity and no permanent disability.
  • Modified unilateral, nerve-sparing RPLND is a safe and effective procedure with excellent functional outcomes.
  • The findings support RPLND as a viable option for risk-benefit analysis against surveillance and chemotherapy.